Humacyte, Inc.
Author: Michael
BlueRock Therapeutics, a wholly owned subsidiary
Milestones plus escalating royalties position Ge
Company plans to move ‘swiftly’ into efficac
Denali Therapeutics announced that the US Food an
A coalition of ALS patients and families has file
ProtoBind-Diff generates novel compounds from pr
Platform can help uncover how aging contributes
OBS Founder Marie Kruth reflects on a night of c
GenSight Biologics announced it has closed a priv